These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31636245)

  • 1. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer.
    Malfitano AM; Somma SD; Prevete N; Portella G
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31636245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic viruses.
    Bifulco M; Di Zazzo E; Napolitano F; Malfitano AM; Portella G
    Biochimie; 2023 Mar; 206():89-92. PubMed ID: 36273765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy.
    Zhang Y; Li Y; Chen K; Qian L; Wang P
    Cancer Cell Int; 2021 May; 21(1):262. PubMed ID: 33985527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy.
    Liu X; Zhao J; Li X; Lao F; Fang M
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viruses as nanomedicine for cancer.
    Badrinath N; Heo J; Yoo SY
    Int J Nanomedicine; 2016; 11():4835-4847. PubMed ID: 27703350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SnapShot: Cancer Immunotherapy with Oncolytic Viruses.
    Gujar S; Bell J; Diallo JS
    Cell; 2019 Feb; 176(5):1240-1240.e1. PubMed ID: 30794777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.
    Wei D; Xu J; Liu XY; Chen ZN; Bian H
    Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Oncolytic Viruses in the Treatment of Melanoma.
    Bayan CY; Lopez AT; Gartrell RD; Komatsubara KM; Bogardus M; Rao N; Chen C; Hart TD; Enzler T; Rizk EM; Pradhan JS; Marks DK; Geskin LJ; Saenger YM
    Curr Oncol Rep; 2018 Aug; 20(10):80. PubMed ID: 30145781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune System, Friend or Foe of Oncolytic Virotherapy?
    Filley AC; Dey M
    Front Oncol; 2017; 7():106. PubMed ID: 28589085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
    Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
    BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arming oncolytic viruses to leverage antitumor immunity.
    de Gruijl TD; Janssen AB; van Beusechem VW
    Expert Opin Biol Ther; 2015 Jul; 15(7):959-71. PubMed ID: 25959450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements.
    Jin KT; Du WL; Liu YY; Lan HR; Si JX; Mou XZ
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy.
    Wang X; Zhao X; He Z
    Oncol Lett; 2021 Apr; 21(4):238. PubMed ID: 33664802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy.
    Rahman MM; McFadden G
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer.
    Wang Z; Sun P; Li Z; Xiao S
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic virotherapy: new weapon for breast cancer treatment.
    Martini V; D'Avanzo F; Maggiora PM; Varughese FM; Sica A; Gennari A
    Ecancermedicalscience; 2020; 14():1149. PubMed ID: 33574894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
    Russell L; Peng KW; Russell SJ; Diaz RM
    BioDrugs; 2019 Oct; 33(5):485-501. PubMed ID: 31321623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
    Choi AH; O'Leary MP; Fong Y; Chen NG
    Biomedicines; 2016 Aug; 4(3):. PubMed ID: 28536385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cells and Tumor-Killing Virus to Target Brain Tumor: In Pursuit to Bring a Potential Delivery Vehicle for the Central Nervous System Tumors.
    E VB; Ranganath Pai KS
    Curr Drug Deliv; 2024; 21(1):2-15. PubMed ID: 36825709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
    Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
    Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.